熱門資訊> 正文
Dianthus Therapeutics推出1.5亿美元承销公开募股
2025-09-09 04:07
- Dianthus Therapeutics (NASDAQ:DNTH) has commenced an underwritten public offering of $150M of its shares of its common stock, pre-funded warrants to purchase shares of its common stock.
- Dianthus intends to use the net proceeds from this offering to advance the company’s preclinical and clinical development activities, as well as for working capital and general corporate purposes.
- DNTH -7.05% after hours to $29.46.
- Source: Press Release
More on Dianthus Therapeutics
- Seeking Alpha’s Quant Rating on Dianthus Therapeutics
- Historical earnings data for Dianthus Therapeutics
- Financial information for Dianthus Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。